Effect of Propranolol on the Activity of Neutral, Alkaline and Acidic Proteases in Rat Myocardium After Aortic Stenosis

Overview

Journal Basic Res Cardiol

Specialty Cardiology & Vascular Diseases

Date 1987 Jan 1

PMID 2954534

Authors

B Kwiatkowska-Patzer

T Zalewska

Affiliations

Soon will be listed here.

Abstract

The aim of the study was to investigate the effect of propranolol upon the activity of proteases in rat myocardium subjected to aortic stenosis. In acute heart hypertrophy induced by aortic stenosis, the activity of all three proteases in the myocardium does not change significantly. Propranolol in the concentration of 10(-6) to 2 X 10(-4) M inhibited proteolytic activity dependent on neutral proteases. The degree of inhibition increased simultaneously with increasing concentrations of propranolol. Propranolol in a low concentration (10(-6)-10(-5) M) also inhibited proteolytic activity dependent on alkaline and acidic proteases, but in higher concentration (10(-4)-2 X 10(-4) M) stimulated proteolytic activity of these enzymes 2-3 times.

References

Croxson R, Khanna P, Raphael M, STEINER R, Oakley C, Goodwin J . Cardioselective beta blockade in hypertrophic cardiomyopathy. Acta Cardiol. 1972; :Suppl 15:263-7. DOI: 10.1016/0002-9149(70)90559-x. View

Rozek R, Kuo T, Giacomelli F, Wiener J . Proteolytic activities in hypertensive cardiomyopathy of rats. J Mol Cell Cardiol. 1983; 15(3):173-87. DOI: 10.1016/0022-2828(83)90297-3. View

Kuo T, Giacomelli F, Kithier K, Malhotra A . Biochemical characterization and cellular localization of serine protease in myopathic hamster. J Mol Cell Cardiol. 1981; 13(12):1035-49. DOI: 10.1016/0022-2828(81)90294-7. View

Smith A, BIRD J . Distribution and particle properties of the vacuolar apparatus of cardiac muscle tissue. I. Biochemical characterization of cardiac muscle lysosomes and the isolation and characterization of acid, neutral and alkaline proteases. J Mol Cell Cardiol. 1975; 7(1):39-61. DOI: 10.1016/0022-2828(75)90005-x. View

Kwiatkowska-Patzer B, Zalewska T . Effect of propranolol upon protein and proteolytic synthesis activity in hypertrophic myocardium. Basic Res Cardiol. 1988; 83(1):43-7. DOI: 10.1007/BF01907103. View

Reddy M, Etlinger J, Rabinowitz M, Fischman D, Zak R . Removal of Z-lines and alpha-actinin from isolated myofibrils by a calcium-activated neutral protease. J Biol Chem. 1975; 250(11):4278-84. View

Wildenthal K, Wakeland J, Ord J, Stull J . Interference with lysosomal proteolysis fails to reduce cardiac myosin degradation. Biochem Biophys Res Commun. 1980; 96(2):793-8. DOI: 10.1016/0006-291x(80)91424-2. View

KAR N, Pearson C . A calcium-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta. 1976; 73(2):293-7. DOI: 10.1016/0009-8981(76)90175-3. View

Sanada Y, Yasogawa N, Katunuma N . Serine protease in mice with hereditary muscular dystrophy. J Biochem. 1978; 83(1):27-33. DOI: 10.1093/oxfordjournals.jbchem.a131901. View

10.

Hubner P, Ziady G, Lane G, Hardarson T, SCALES B, Oakley C . Double-blind trial of propranolol and practolol in hypertrophic cardiomyopathy. Br Heart J. 1973; 35(11):1116-23. PMC: 458765. DOI: 10.1136/hrt.35.11.1116. View

11.

Kuo T, Ho K, Wiener J . The role of alkaline protease in the development of cardiac lesions in myopathic hamsters: effect of verapamil treatment. Biochem Med. 1984; 32(2):207-15. DOI: 10.1016/0006-2944(84)90074-7. View

12.

Kuo T, Bhan A . Studies of a myosin-cleaving protease from dystrophic hamster heart. Biochem Biophys Res Commun. 1980; 92(2):570-6. DOI: 10.1016/0006-291x(80)90371-x. View

13.

DeMartino G, GOLDBERG A . Identification and partial purification of an ATP-stimulated alkaline protease in rat liver. J Biol Chem. 1979; 254(10):3712-5. View

14.

Woodbury R, Everitt M, Sanada Y, Katunuma N, Lagunoff D, NEURATH H . A major serine protease in rat skeletal muscle: evidence for its mast cell origin. Proc Natl Acad Sci U S A. 1978; 75(11):5311-3. PMC: 392952. DOI: 10.1073/pnas.75.11.5311. View

15.

Zak R, Rabinowitz M . Molecular aspects of cardiac hypertrophy. Annu Rev Physiol. 1979; 41:539-52. DOI: 10.1146/annurev.ph.41.030179.002543. View

16.

Swanton R, Brooksby I, Jenkins B, Webb-Peploe M . Hemodynamic studies of beta blockade in hypertrophic obstructive cardiomyopathy. Eur J Cardiol. 1977; 5(4):327-41. View

17.

Dayton W, Schollmeyer J, Lepley R, Cortes L . A calcium-activated protease possibly involved in myofibrillar protein turnover. Isolation of a low-calcium-requiring form of the protease. Biochim Biophys Acta. 1981; 659(1):48-61. DOI: 10.1016/0005-2744(81)90270-9. View

18.

Wildenthal K . Lysosomal alterations in ischemic myocardium: result or cause of myocellular damage?. J Mol Cell Cardiol. 1978; 10(7):595-603. DOI: 10.1016/s0022-2828(78)80001-7. View

19.

Rose I, WARMS J, Hershko A . A high molecular weight protease in liver cytosol. J Biol Chem. 1979; 254(17):8135-8. View

20.

Albin R, Dowell R, Zak R, Rabinowitz M . Synthesis and degradation of mitochondrial components in hypertrophied rat heart. Biochem J. 1973; 136(3):629-37. PMC: 1165998. DOI: 10.1042/bj1360629. View